Publicaciones en las que colabora con JAVIER RUIZ MARTÍNEZ (11)
2024
-
A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells
npj Parkinson's Disease, Vol. 10, Núm. 1
2023
-
Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson’s disease
npj Parkinson's Disease, Vol. 9, Núm. 1
-
Falls Predict Acute Hospitalization in Parkinson's Disease
Journal of Parkinson's disease, Vol. 13, Núm. 1, pp. 105-124
-
Frequency and phenotypic spectrum of spinocerebellar ataxia 27B and other genetic ataxias in a Spanish cohort of late-onset cerebellar ataxia
European Journal of Neurology, Vol. 30, Núm. 12, pp. 3828-3833
2022
-
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
npj Parkinson's Disease, Vol. 8, Núm. 1
2021
-
A More Homogeneous Phenotype in Parkinson's Disease Related to R1441G Mutation in the LRRK2 Gene
Frontiers in Neurology, Vol. 12
-
R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils
Acta Neuropathologica, Vol. 142, Núm. 3, pp. 475-494
2020
-
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
The Lancet Neurology, Vol. 19, Núm. 1, pp. 71-80
-
Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients
Annals of Clinical and Translational Neurology, Vol. 7, Núm. 10, pp. 1816-1830
2019
-
Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)
Parkinsonism and Related Disorders, Vol. 62, pp. 201-209
-
The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight
Movement Disorders, Vol. 34, Núm. 12, pp. 1851-1863